Skip to main content Back to Top
Advertisement

11/15/2019

Aminophylline Injection

Products Affected - Description

    • Aminophylline intravenous solution for injection, Pfizer, 25 mg/mL, 10 mL single dose vial, 25 count, NDC 00409-5921-01
    • Aminophylline intravenous solution for injection, Pfizer, 25 mg/mL, 20 mL single dose vial, 25 count, NDC 00409-5922-01

Reason for the Shortage

    • Pfizer has aminophylline injection on shortage due to manufacturing delays.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Pfizer has aminophylline 25 mg/mL 20 mL vials on back order and the company estimates a release date of November 2019. There are short-dated 25 mg/mL 10 mL vials available with an expiration date of April 2020.

Safety

    • Pfizer, in conjunction with FDA, has been able to extend the labeled expiration date of 4 lots of aminophylline injection from October 1, 2018 to February 1, 2019. There are 3 lots from the 25 mg/mL 10 mL vials (NDC 00409-5921-01). These lot number are 76328DK, 76329DK, and 76330DK). The other lot is from the 25 mg/mL 20 mL vials (NDC 00409-5922-01). This lot is 76331DK.

Updated

Updated November 15, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 28, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins